Achievements


Crystal Life Sciences (CLS) was established in the month of Apr 2010. Since its inception, CLS has not seen back. Many trials carried out and were successfully completed to the satisfaction of sponsor. At the end of the every trial, sponsor responded greatly with a “wonderful experience with Crystal Life Sciences” and expressed their intention to continue relations for future trials.

Some of the clinical trials carried out by Crystal Life Sciences are as follows:

Head and Neck Cancer Trial

Crystal Life Sciences (CLS) carried out one of the clinical trial – Ca Head and Neck Phase II, multicentric, double-Blind, Placebo-controlled. The trial was sponsored by Piramal Life Sciences Ltd which is located at Mumbai (Maharashtra (India). The trial lasted for 1 and half year. The trial was successfully completed.

Chronic Kidney Disease with Anemia

Patients with Chronic Kidney disease on dialysis with Anemia, Phase III trial was carried out by Crystal Life Sciences which was sponsored by Emcure Pharmaceuticals Ltd, one of the Multi-National Company (MNC) which is located at Pune (Maharashtra) (India). The trial lasted for six months. The trial was successfully completed.

Diabetes Mellitus

Phase II trial for newly detected treatment naïve subjects having Diabetes Mellitus has been carried out by Crystal Life Sciences which was sponsored by Piramal Life Sciences Ltd. It lasted for six months. The trial was successfully completed.

Ophthalmic Solution

Phase III clinical study for Ophthalmic Solution for treatment of patients with Dry Eye has been carried out by Crystal Life Sciences which was sponsored by Ajanta Pharma Limited. It lasted for more than a year. The trial has been completed successfully.

Head and Neck Cancer (Phase 1b)

Phase I clinical trial project for Clinical Data Management (CDM) has been completed successfully by Crystal Life Sciences within stipulated time. This project was sponsored by RA Chem Pharma Limited and due to delay in getting regulatory approval, it lasted for three years. But, on getting regulatory approvals, Crystal Life Sciences completed it at very fast pace and on completing it successfully, resultant report submitted to the sponsor with very high-quality.

Head and Neck Cancer (Phase 2a)

On successful completion of Phase 1b clinical trial project for Clinical Data Management (CDM), United State of America (USA) based sponsor named Tosk Inc asked Crystal Life Sciences to carry out their Phase 2a clinical trial from the scratch as CRO. Crystal Life Sciences availed an opportunity of carrying out offshore project. Started work with full energy and carried out all works from getting regulatory approvals within stipulated time to the reporting of final clinical trial study report. Thus, Crystal Life Sciences completed the project in one and half year with high quality resultant report at the end of the clinical trial for which sponsor appreciated the high-quality work done by Crystal Life Sciences.

Chronic Kidney Disease (CKD) Not on Dialysis. (DREAM-ND)

Crystal Life Sciences has carried out clinical trial for Phase 3 - Chronic Kidney Disease (CKD) subject not on Dialysis which was sponsored by Cadila Healthcare Ltd. The project is completed successfully within stipulated time frame.

Chronic Kidney Disease (CKD) on Dialysis. (DREAM-D)

Presently, Crystal Life Sciences is in process of carrying out clinical trial for Phase 3 - Chronic Kidney Disease (CKD) on Dialysis which is sponsored by Cadila Healthcare Ltd. The project is in progress since last one year, but due to pandemic (COVID19) situation it is taking little more time to complete. However, despite pandemic situation, all works at our level are in full swing and it looks like, it will be completed soon.

Trial carrying out records of Crystal Life Sciences proved excellent and without any hassle. So, Crystal Life Sciences has proud of being the successful and hassle free Contract/ Clinical Research Organization (CRO). Presently, many of the sponsors are showing interest in our organization for outsourcing clinical trials for which we are looking forward to extend our support to fulfill their requirements.